Ultime notizie per Gevo (NASDAQ:GEVO) Azioni

Gevo

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.

Gevo Inc

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $11.31, a high estimate of $14.00, and a low estimate of $3.25. Marking an increase of 5.6%, the current average surpasses the previous average price target of $10.71. 
<img src="https://www.benzinga.com/files/images/story/2024/1731502828_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Gevo among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$3.25</td>
<td>$0.85</td>
</tr>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Gevo. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Gevo compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
For valuable insights into Gevo's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/GEVO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Gevo analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Gevo</h2>
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.
<h3>A Deep Dive into Gevo's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Gevo showcased positive performance, achieving a revenue growth rate of 24.12% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Gevo's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -399.28%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -3.95%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Gevo's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -3.36%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Gevo's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.14.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

GEVO

Analyst Ratings For Gevo

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.

News

Price Target

Reiteration

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

<a href="https://x.com/IcebergResear/status/1854961131745690053">https://x.com/IcebergResear/status/1854961131745690053</a>
We are short Gevo Inc ($GEVO). The change in the US administration is the obvious threat but problems run deeper, in particular the competitiveness of technology. A lot of room to fall further.
In its last days, the Biden-driven Department of Energy has granted conditional approval for a $1.46b loan to Gevo, aimed at building a plant to produce alcohol-to-jet ("ATJ") aviation fuel.
Under a Trump-led administration, who called the IRA a "Green New Scam", Gevo's project is one of the most vulnerable DOE conditional approvals. The massive loan is subject to multiple conditions before approval, placing control in the hands of the DOE's new leadership.
Sustainable aviation fuels (SAF), whether HEFA or ATJ, are structurally more expensive than traditional jet fuel, and rely heavily on tax credits e.g. IRA and RFS. Generous IRA credits are now threatened and in any case, they expire in 2027.
ATJ (Gevo's type) is also more expensive than HEFA, the most common type of SAF (see above). Bulls argue HEFA will face future feedstock supply constraints (e.g. used oil), hence the need for ATJ.
The EU has mandated 6% SAF use by 2030, but even when the rule is implemented, current and incoming HEFA production will more than cover demand.
In the US, the DOE believes that HEFA won't cover SAF needs in 2030. But the DOE has assumed SAF would account for 12% (3b gal) of all fuel usage (25b gal) even though SAF adoption will be voluntary in the US, while Europe's 6% is mandatory.
Hard to believe that US airlines would voluntarily use twice more SAF than their European peers while airline margins are notoriously thin. Assuming 6% usage, in line with the EU in 2030, we found that expected US HEFA capacity (1.7b) will cover SAF needs (1.5b gal).
Worse, the electrification of vehicles will reduce the usage of renewable diesel, which shares the same feedstock as HEFA. This would release HEFA supply in favour of SAF. Another issue is that the EU bans crop-based biofuels like corn. Corn is Gevo's primary feedstock.
The track record of operators is crucial for a project as large as Gevo's ATJ plant. Gevo is known to have a history of under-delivering on promises. In 2019 for example, management unveiled plans to achieve $63-$77m of revenue in 2021. Actual revenue for the year was $0.5m.
Since 2013, the company has burnt through $678m of cash, and raised $887m in common equity. Share count has grown about 16x since 2019. Still, top managers received very attractive compensation packages despite this poor performance.
We believe the shifting political landscape and the challenging economics of ATJ make Gevo's renewable project highly speculative and prone to failure.

Short Sellers

Trading Ideas

Iceberg Research Posts On X "We are short Gevo Inc ($GEVO). The change in the US administration is the obvious threat but problems run deeper, in particular the competitiveness of technology. A lot of room to fall further."

Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. The company reported quarterly sales of $1.965 million which missed the analyst consensus estimate of $5.420 million by 63.74 percent. This is a 56.60 percent decrease over sales of $4.528 million the same period last year.

Earnings

Earnings Misses

Gevo Q3 2024 GAAP EPS $(0.09) Misses $(0.07) Estimate, Sales $1.965M Miss $5.420M Estimate

<a href="https://www.bleeckerstreetresearch.com/research/gevo" title="https://www.bleeckerstreetresearch.com/research/gevo">https://www.bleeckerstreetresearch.com/research/gevo</a>

Watching Shares Of Gevo; Bleecker Street Research Issues Report On The Co; Says "We believe a Trump DOE is much less likely to approve the loan, as the DOE's multibillion-dollar loan program is known to be in Trump's crosshairs"

Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) will release its quarterly earnings report on Thursday, 2024-11-07. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Gevo to report an earnings per share (EPS) of $-0.07.
The announcement from Gevo is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.00, leading to a 0.02% increase in the share price the following trading session.
Here's a look at Gevo's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.09</td>
<td>-0.07</td>
<td>-0.05</td>
<td>-0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.09</td>
<td>-0.08</td>
<td>-0.08</td>
<td>-0.07</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>-0.0%</td>
<td>-4.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730926943_0.png" alt="eps graph" />
<h3>Performance of Gevo Shares</h3>
Shares of Gevo were trading at $2.35 as of November 05. Over the last 52-week period, shares are up 61.13%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Opinions on Gevo</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Gevo.
A total of 4 analyst ratings have been received for Gevo, with the consensus rating being Buy. The average one-year price target stands at $11.31, suggesting a potential 381.28% upside.
<h3>Peer Ratings Comparison</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Clean Energy Fuels, REX American Resources and Green Plains, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>For Clean Energy Fuels, analysts project an Outperform trajectory, with an average 1-year price target of $6.0, indicating a potential 155.32% upside.</li>
<li>REX American Resources is maintaining an Buy status according to analysts, with an average 1-year price target of $60.0, indicating a potential 2453.19% upside.</li>
<li>The prevailing sentiment among analysts is an Buy trajectory for Green Plains, with an average 1-year price target of $20.75, implying a potential 782.98% upside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
Within the peer analysis summary, vital metrics for Clean Energy Fuels, REX American Resources and Green Plains are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gevo</td>
<td>Buy</td>
<td>24.12%</td>
<td>$1.84M</td>
<td>-3.95%</td>
</tr>
<tr>
<td>Clean Energy Fuels</td>
<td>Outperform</td>
<td>8.18%</td>
<td>$22.75M</td>
<td>-2.25%</td>
</tr>
<tr>
<td>REX American Resources</td>
<td>Buy</td>
<td>-30.11%</td>
<td>$19.77M</td>
<td>2.33%</td>
</tr>
<tr>
<td>Green Plains</td>
<td>Buy</td>
<td>-26.21%</td>
<td>$78.11M</td>
<td>5.38%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Gevo is positioned at the bottom for Revenue Growth among its peers. It ranks at the bottom for Gross Profit as well. Gevo is at the top for Return on Equity.
<h3>About Gevo</h3>
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.
<h3>Financial Insights: Gevo</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Gevo's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 24.12%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: Gevo's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -399.28%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Gevo's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -3.95%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Gevo's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -3.36%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.14.
<a href="https://www.benzinga.com/quote/GEVO/earnings">To track all earnings releases for Gevo visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For Gevo

U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Wednesday.
Shares of Exact Sciences Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected third-quarter financial results and issued FY24 revenue <a href="https://www.benzinga.com/general/biotech/24/11/41760212/exact-sciences-stock-plummets-after-worse-than-expected-q3-results-fy24-guidance-below-estimates">guidance below estimates</a>.
Exact Sciences reported quarterly GAAP losses of 21 cents per share, which missed the analyst consensus estimate for losses of 20 cents. Quarterly sales of $709 million missed the consensus estimate of $717.66 million.
Exact Sciences shares dipped 27% to $52.20 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) fell 24.3% to $20.97 in pre-market trading after the company lowered its financial outlook. The company expects to report first-quarter revenue of $5.9 billion to $6 billion, down from its previous guidance range of $6 billion to $7 billion. The company anticipates adjusted earnings of 75 cents to 76 cents per share, versus its previous guidance of 67 cents to 83 cents per share.</li>
<li>Gevo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) fell 20.8% to $1.86 in today's pre-market trading.</li>
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) fell 20.1% to $5.64 in pre-market trading after gaining 8% on Tuesday.</li>
<li>PACS Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACS#NYSE">PACS</a>) shares fell 18.8% to $24.00 in pre-market trading after the company announced postponement of third-quarter results and disclosure on civil investigative demands from the federal government.</li>
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) fell 18.6% to $13.76 in pre-market trading after gaining 5% on Tuesday.</li>
<li>Evotec SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) declined 16.8% to $3.81 in pre-market trading following weak quarterly results.</li>
<li>Oscar Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) shares fell 16.8% to $15.25 in pre-market trading.</li>
<li>First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) shares fell 14.7% to $184.00 in pre-market trading.</li>
<li>The AES Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) declined 9.9% to $13.97 in pre-market trading.</li>
<li>Honda Motor Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) shares fell 7.4% to $28.05 in pre-market trading as the company said profits fell around 20% in the first half of the fiscal year.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

EXAS

FSLR

NOVA

OSCR

PACS

SMCI

Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose sharply in today's pre-market trading over a likely Donald Trump victory in the <a href="https://www.benzinga.com/markets/equities/24/11/41767527/tesla-stock-surges-over-13-in-premarket-what-is-going-on">U.S. Presidential elections</a>.
According to The New York Times, Trump currently has over 95% chance of victory given he already has 267 of the 270 electoral votes needed to win. Tesla CEO Elon Musk endorsed Trump in July and has been actively campaigning for the former President both offline and online. Musk even campaigned for Trump in the swing state of Pennsylvania in October.
Tesla shares rose 14% to $286.57 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) gained 117% to $0.2954 in pre-market trading. FOXO Technologies, last month, said its interim CFO wrote to shareholders expectations to build the business over the next 12-24 months and generate more than $50 million a year in revenue.</li>
<li>ARB IOT Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) rose 93.1% to $1.09 in pre-market trading after the company signed a MOU to accelerate AI with advanced server solutions.</li>
<li>The GEO Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) shares surged 30.7% to $19.78 in pre-market trading after gaining around 7% on Tuesday.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) gained 26.6% to $42.98 in pre-market trading.</li>
<li>DatChat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) climbed 25.8% to $2.25 in pre-market trading.</li>
<li>Qualys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) shares rose 22.4% to $156.96 in pre-market trading after the company reported better-than-expected third-quarter financial results, raised its FY24 guidance, and issued fourth-quarter revenue guidance above estimates.</li>
<li>Destiny Tech100 Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXYZ#NASDAQ">DXYZ</a>) gained 22.4% to $14.20 in pre-market trading after gaining 6% on Tuesday.</li>
<li>CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) gained 21.1% to $16.50 in pre-market trading. CoreCivic will release its third quarter financial results after the closing bell on Wednesday, Nov. 6.</li>
<li>Phunware, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) gained 19.6% to $7.62 in pre-market trading after declining around 8% on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Vast Renewables Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) shares tumbled 55.8% to $2.37 in pre-market trading after dipping more than 20% on Tuesday.</li>
<li>Zoomcar Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares fell 42.5% to $7.56 in pre-market trading after the company announced the pricing of $9.15 million private placement.</li>
<li>Li-Cycle Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LICY#NYSE">LICY</a>) dipped 27.6% to $2.75 in pre-market trading. Li-Cycle to host third quarter earnings conference call/webcast on Thursday, Nov. 7.</li>
<li>Exact Sciences Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) shares fell 27% to $52.20 in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Simpple Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) declined 27% to $1.23 in pre-market trading. Simpple shares jumped 43% on Tuesday after the company announced its plan to regain NASDAQ compliance.</li>
<li>Bluejay Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) shares dipped 25.9% to $0.1015 in pre-market trading after gaining 88% on Tuesday.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) fell 24.3% to $20.97 in pre-market trading after the company lowered its financial outlook. The company expects to report first-quarter revenue of $5.9 billion to $6 billion, down from its previous guidance range of $6 billion to $7 billion. The company anticipates adjusted earnings of 75 cents to 76 cents per share, versus its previous guidance of 67 cents to 83 cents per share.</li>
<li>Bionomics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNOX#NASDAQ">BNOX</a>) fell 22.8% to $0.3806 in pre-market trading. Bionomics shares jumped 157% on Tuesday after the company announced it secured an AUS$1 million milestone payment from Carina Biotech for its BNC101 oncology program, with the potential to earn up to AUS$118 million.</li>
<li>Gevo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) fell 20.8% to $1.86 in today's pre-market trading.</li>
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) fell 20.1% to $5.64 in pre-market trading after gaining 8% on Tuesday.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

ARBB

BJDX

BNOX

DATS

DXYZ

FOXO

LICY

PHUN

QLYS

SPPL

TSLA

VSTE

ZCAR

Why Tesla Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

WIIM

CGBS

CSAN

FANG

GPRE

NCSM

PUMP

RCON

Shares of oil and gas companies are trading higher following reports suggesting OPEC+ will delay output increases.

Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $11.31, a high estimate of $14.00, and a low estimate of $3.25. This current average has increased by 5.6% from the previous average price target of $10.71. 
<img src="https://www.benzinga.com/files/images/story/2024/1729620082_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Gevo's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$3.25</td>
<td>$0.85</td>
</tr>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Gevo. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Gevo compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Gevo's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Gevo's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/GEVO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Gevo analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Gevo</h2>
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.
<h3>Breaking Down Gevo's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Gevo's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 24.12%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Gevo's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -399.28%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Gevo's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -3.95%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -3.36%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Gevo's debt-to-equity ratio is below the industry average at 0.14, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Gevo: Insights From 4 Financial Analysts

Analysts' ratings for Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $11.31, a high estimate of $14.00, and a low estimate of $3.25. This current average reflects an increase of 5.6% from the previous average price target of $10.71. 
<img src="https://www.benzinga.com/files/images/story/2024/1729609275_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of Gevo's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$3.25</td>
<td>$0.85</td>
</tr>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Amit Dayal</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Gevo. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Gevo compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Gevo's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Gevo's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/GEVO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Gevo analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Gevo's Background</h2>
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.
<h3>Financial Insights: Gevo</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Gevo's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 24.12%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Gevo's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -399.28%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Gevo's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -3.95%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Gevo's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -3.36%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Gevo's debt-to-equity ratio is below the industry average. With a ratio of 0.14, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Evaluating Gevo: Insights From 4 Financial Analysts

UBS analyst Manav Gupta maintains Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Neutral and raises the price target from $0.85 to $3.25.

UBS Maintains Neutral on Gevo, Raises Price Target to $3.25

Gevo shares are trading higher. HC Wainwright & Co. reiterated a Buy rating on the stock.

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 90 points on Friday.
Shares of CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) fell sharply in today's pre-market trading after the company cut its <a href="https://www.benzinga.com/quote/CVS">third-quarter outlook.</a>
CVS Health appointed longtime executive David Joyner as its new president and CEO, replacing Karen Lynch amid the company's ongoing financial struggles. The company warned that its upcoming third-quarter earnings, set for release on November 6, will miss Wall Street projections.
CVS Health shares dipped 11.6% to $56.29 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>MGP Ingredients, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) shares dipped 16.6% to $68.06 after the company issued soft preliminary guidance and lowered its 2024 financial outlook.</li>
<li>Coherent Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NASDAQ">COHR</a>) shares fell 4.6% to $97.39 in pre-market trading.</li>
<li>Zeta Global Holdings Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) shares fell 4.5% to $28.66 in pre-market trading. Zeta is expected to release its third quarter 2024 financial results after the closing bell on Monday, Nov. 11.</li>
<li>Jin Medical International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJYL#NASDAQ">ZJYL</a>) shares fell 4.3% to $2.03 in pre-market trading after declining around 5% on Thursday.</li>
<li>GrafTech International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NASDAQ">EAF</a>) shares fell 4.1% to $1.62 in pre-market trading.</li>
<li>Gevo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) shares fell 3.8% to $2.55 in pre-market trading. HC Wainwright &amp; Co. analyst Amit Dayal reiterated Gevo with a Buy and maintained a $14 price target.</li>
<li>American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) shares fell 3.6% to $275.50 in pre-market trading following third-quarter results.</li>
<li>Fresh Del Monte Produce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) shares fell 3.5% to $29.00 in pre-market trading. Fresh Del Monte Produce will issue a press release on its third quarter financial results prior to market opening on Thursday, Oct. 31.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41390636/top-2-real-estate-stocks-that-may-fall-off-a-cliff-in-q4">Top 2 Real Estate Stocks That May Fall Off A Cliff In Q4</a></li>
</ul>

COHR

MGPI

ZETA

ZJYL

CVS Health Cuts Outlook, Joins American Express And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 recording gains on Thursday.
The Dow traded up 0.24% to 43,179.49 while the NASDAQ rose 0.24% to 18,411.77. The S&amp;P 500 also rose, gaining, 0.08% to 5,847.03.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41377157/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a>
Leading and Lagging Sectors Information technology shares jumped by 0.8% on Thursday.
In trading on Thursday, communication services shares fell by 0.7%.
Top Headline
U.S. crude oil inventories declined by 2.192 million barrels in the week ended Oct. 11, versus estimates of a 2.3 million gain, the EIA said.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Gevo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) shares shot up 18% to $2.6650 after the company announced it secured a DOE conditional commitment loan of $1.46 billion for its net-zero 1 sustainable aviation fuel plant in South Dakota.</li>
<li>Shares of Nixxy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIXX#NASDAQ">NIXX</a>) got a boost, surging 52% to $3.6010 after the company provided updates on the business including its acquisition strategy in traditional markets and enhancing operations through technology and data analytics.</li>
<li>Iridium Communications Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) shares were also up, gaining 12% to $33.97 after the company reported better-than-expected third-quarter revenue results and raised its FY24 OEBITDA guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Proficient Auto Logistics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAL#NASDAQ">PAL</a>) shares dropped 28% to $10.10 after the company announced it expects its third-quarter net income to be significantly degraded due to a reduced level of revenue and resulting loss of operating leverage. Also, the company said it expects that the Longshoremen strike could have negatively impacted unit volumes during the fourth quarter and beyond.</li>
<li>Shares of Cerus Corporation. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERS#NASDAQ">CERS</a>) were down 18% to $1.4750 after the company provided updates on its INTERCEPT red blood cell programs in the US and Europe.</li>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) was down, falling 16% to $2.75 after the company announced the pricing of an offering and corresponding investment from an affiliate of the Public Investment Fund (PIF).</li>
</ul>
Commodities In commodity news, oil traded down 0.3% to $70.19 while gold traded up 0.7% at $2,709.00.
Silver traded down 0.5% to $31.83 on Thursday, while copper fell 0.9% to $4.3270.
Euro zone
European shares closed mostly higher today. The eurozone's STOXX 600 gained 0.83%, Germany's DAX rose 0.77% and France's CAC 40 climbed 1.22%. Spain's IBEX 35 Index fell 0.77%, while London's FTSE 100 gained 0.67%.
The European Central Bank cut its three key interest rates by 25 bps in October. Annual inflation rate in the Eurozone fell to 1.7% in September versus initial estimates of 1.8% and compared to 2.2% in August.
Asia Pacific Markets
Asian markets closed lower on Thursday, with Japan's Nikkei 225 falling 0.69%, Hong Kong's Hang Seng Index falling 1.02%, China's Shanghai Composite Index dipping 1.05% and India's BSE Sensex falling 0.61%.
Economics
<ul>
<li>Industrial production in the U.S. declined 0.3% from a month ago in September.</li>
<li>U.S. initial jobless claims fell by 19,000 in the week ending Oct. 12.</li>
<li>The Philadelphia Fed Manufacturing Index climbed to 10.3 in October compared to 1.7 in September and topping market estimates of 3.</li>
<li>U.S. retail sales rose 0.4% month-over-month in September compared to a 0.1% increase in August and higher than market estimates of a 0.3% rise.</li>
<li>Total business inventories increased by 0.3% month-over-month in August.</li>
<li>The NAHB/Wells Fargo Housing Market Index climbed to 43 in October from 41 in the prior month.</li>
<li>U.S. natural-gas stocks increased 76 billion cubic feet during the week ended Oct. 11, compared to market estimates of a 78 billion cubic feet gain.</li>
<li>U.S. crude oil inventories declined by 2.192 million barrels in the week ended Oct. 11, versus estimates of a 2.3 million gain, the EIA said.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41377581/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yiel"> Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

CERS

IRDM

LCID

NIXX

S&P 5000 Edges Higher; US Crude Oil Inventories Fall

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Thursday.
The Dow traded up 0.28% to 43,199.12 while the NASDAQ rose 0.53% to 18,464.23. The S&amp;P 500 also rose, gaining, 0.30% to 5,860.00.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41377157/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a>
Leading and Lagging Sectors Information technology shares jumped by 1.1% on Thursday.
In trading on Thursday, real estate shares fell by 0.6%.
Top Headline
U.S. retail sales rose 0.4% month-over-month in September compared to a 0.1% increase in August and higher than market estimates of a 0.3% rise.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Gevo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) shares shot up 18% to $2.6450 after the company announced it secured a DOE conditional commitment loan of $1.46 billion for its net-zero 1 sustainable aviation fuel plant in South Dakota.</li>
<li>Shares of Nixxy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIXX#NASDAQ">NIXX</a>) got a boost, surging 116% to $5.12 after the company provided updates on the business including its acquisition strategy in traditional markets and enhancing operations through technology and data analytics.</li>
<li>Iridium Communications Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) shares were also up, gaining 16% to $35.11 after the company reported better-than-expected third-quarter revenue results and raised its FY24 OEBITDA guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Proficient Auto Logistics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAL#NASDAQ">PAL</a>) shares dropped 23% to $10.68 after the company announced it expects its third-quarter net income to be significantly degraded due to a reduced level of revenue and resulting loss of operating leverage. Also, the company said it expects that the Longshoremen strike could have negatively impacted unit volumes during the fourth quarter and beyond.</li>
<li>Shares of Cerus Corporation. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERS#NASDAQ">CERS</a>) were down 20% to $1.4486 after the company provided updates on its INTERCEPT red blood cell programs in the US and Europe.</li>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) was down, falling 15% to $2.7950 after the company announced the pricing of an offering and corresponding investment from an affiliate of the Public Investment Fund (PIF).</li>
</ul>
Commodities In commodity news, oil traded up 0.5% to $70.76 while gold traded up 0.6% at $2,706.20.
Silver traded down 0.2% to $31.91 on Thursday, while copper fell 0.6% to $4.3435.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.8%, Germany's DAX rose 0.60% and France's CAC 40 climbed 1.23%. Spain's IBEX 35 Index fell 0.6%, while London's FTSE 100 gained 0.56%.
The European Central Bank cut its three key interest rates by 25 bps in October. Annual inflation rate in the Eurozone fell to 1.7% in September versus initial estimates of 1.8% and compared to 2.2% in August.
Asia Pacific Markets
Asian markets closed lower on Thursday, with Japan's Nikkei 225 falling 0.69%, Hong Kong's Hang Seng Index falling 1.02%, China's Shanghai Composite Index dipping 1.05% and India's BSE Sensex falling 0.61%.
Economics
<ul>
<li>Industrial production in the U.S. declined 0.3% from a month ago in September.</li>
<li>U.S. initial jobless claims fell by 19,000 in the week ending Oct. 12.</li>
<li>The Philadelphia Fed Manufacturing Index climbed to 10.3 in October compared to 1.7 in September and topping market estimates of 3.</li>
<li>U.S. retail sales rose 0.4% month-over-month in September compared to a 0.1% increase in August and higher than market estimates of a 0.3% rise.</li>
<li>Total business inventories increased by 0.3% month-over-month in August.</li>
<li>The NAHB/Wells Fargo Housing Market Index climbed to 43 in October from 41 in the prior month.</li>
<li>U.S. natural-gas stocks increased 76 billion cubic feet during the week ended Oct. 11, compared to market estimates of a 78 billion cubic feet gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41377581/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yiel"> Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>

Crude Oil Edges Higher; US Retail Sales Top Expectations

U.S. stocks were higher, with the Dow Jones index gaining around 100 points on Thursday.
Shares of The Travelers Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) rose sharply during Thursday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41379650/travelers-q3-triumph-strong-premium-growth-and-underwriting-gains-propel-massive-earnings-beat">third-quarter results</a>.
The Travelers Companies reported third-quarter revenue growth of 12% year-over-year to $11.904 billion, beating the consensus of $11.491 billion. Core income per share jumped 169% to $5.24, beating the $3.64 consensus estimate.
Travelers gained 6.9% to $259.63 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Gevo, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) gained 27.6% to $2.87 after the company announced it secured a DOE conditional commitment loan of $1.46 billion for its net-zero 1 sustainable aviation fuel plant in South Dakota.</li>
<li>Iridium Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) gained 16.2% to $35.09 after the company reported better-than-expected third-quarter revenue results and raised its FY24 OEBITDA guidance.</li>
<li>XCHG Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) climbed 15.2% to $19.60.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) gained 14.7% to $88.74.</li>
<li>SelectQuote, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLQT#NYSE">SLQT</a>) shares gained 14.6% to $2.58 after the company announced it completed the first phase of recapitalization with $100 million securitization transaction.</li>
<li>Taiwan Semiconductor Manufacturing Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) gained 12.6% to $211.14 following a third-quarter earnings beat and strong fourth-quarter guidance.</li>
<li>Amicus Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) gained 11.1% to $11.67 after the company announced it entered into a license agreement with Teva and resolved its Galafold patent litigation.</li>
<li>Webster Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBS#NYSE">WBS</a>) climbed 8.5% to $52.76 following third-quarter results.</li>
<li>Cohen &amp; Steers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNS#NYSE">CNS</a>) gained 7.7% to $109.00 after UBS upgraded the stock from Sell to Neutral and raised its price target from $63 to $102.</li>
<li>Uranium Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UEC#NYSE">UEC</a>) gained 7.3% to $8.54. Uranium Energy increased licensed production capacity to 4 million pounds of U3O8 PER YEAR AT the Irigaray Processing Plant.</li>
<li>Snap-on Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) climbed 7.2% to $319.43 after the company reported better-than-expected third-quarter adjusted EPS results.</li>
<li>GrafTech International Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) gained 7% to $1.6900.</li>
<li>Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) climbed 4.6% to $157.78 following a report suggesting Uber explored a takeover bid for the company.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41377581/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yiel">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>

EXPE

FOLD

SLQT

Travelers Posts Upbeat Results, Joins Iridium Communications, Snap-on And Other Big Stocks Moving Higher On Thursday

Gevo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) shares are trading higher Thursday after the company announced it received a conditional commitment from the <a href="https://www.benzinga.com/government/24/10/41370489/calumet-gevo-shares-are-soaring-wednesday-whats-going-on">U.S. Department of Energy (DOE)</a>.
What Happened: Gevo announced that it received a conditional commitment for a loan guarantee from the DOE's Loan Programs Office, with disbursements totaling&nbsp;$1.46 billion. The commitment is related to the construction of the company's Net-Zero 1 project (NZ1) in South Dakota.
The DOE loan facility has a borrowing capacity of&nbsp;$1.63 billion, including capitalized interest during construction.
Gevo&#8217;s NZ1 facility is designed to produce approximately 60 million gallons of sustainable aviation fuel (SAF), approximately 1.3 billion pounds of protein and animal feed products and approximately 30 million pounds of corn oil per year.&nbsp;The facility is expected to yield SAF with a net-zero carbon footprint on a lifecycle basis.
&#8220;This marks a watershed moment for the Net-Zero 1 project and a critical step forward in Gevo&#8217;s mission to transform the aviation industry by providing a scalable, sustainable, and economical renewable-carbon-based jet fuel—SAF,&#8221; Patrick Gruber, CEO of Gevo.
&#8220;This valuable commitment to help finance NZ1, if finalized, should also attract other capital investments to unlock SAF commercialization given the robust due diligence conducted by the agency.&#8221;
The project design and operating model is expected to serve as a template for future Gevo net-zero projects. The company said it plans to track and verify the sustainability and carbon intensity of its products through subsidiary Verity Holdings.
See Also: <a href="https://www.benzinga.com/news/24/10/41343639/oklo-ceo-highlights-mind-blowing-demand-for-ai-power-says-googles-nuclear-deal-only-tip-of-the-icebe">Oklo CEO Highlights &#8216;Mind-Blowing&#8217; Demand For AI Power, Says Google&#8217;s Nuclear Deal Only &#8216;Tip Of The Iceberg&#8217;</a>
<h2 class="wp-block-heading">How To Buy GEVO Stock</h2>
By now you're likely curious about how to participate in the market for Gevo &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share. In the case of Gevo, which is trading at $2.25 as of publishing time, $100 would buy you 44.44 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
GEVO Price Action: <a href="http://benzinga.com/quote/gevo">Gevo shares</a> were up 33.3% at $3.00 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Pixabay.

Why Gevo Stock Is Surging Thursday — 'This Marks A Watershed Moment'

Gevo shares are trading higher after the company announced it secured a DOE conditional commitment loan of $1.46 billion for its net-zero 1 sustainable aviation fuel plant in South Dakota.

Bleecker Street Research has revealed a short position in alternative biofuel producer Gevo ($GEVO), citing concerns regarding Donald Trump. Now th...

Bleecker Street Research Shorts Gevo (NASDAQ:GEVO) on Trump Concerns

Gevo GAAP EPS of -$0.09 beats by $0.01, revenue of $1.97M misses by $4.11M

Gevo, Inc. (GEVO) Q3 2024 Earnings Call Transcript

Gevo Inc ( ($GEVO) ) has released its Q3 earnings. Here is a breakdown of the information Gevo Inc presented to its investors. Gevo, Inc., a renewa...

Gevo Reports Q3 2024 Financial Results and Strategic Advances

Iceberg Research said via X: "We are short Gevo (GEVO) Inc ($GEVO). The change in the US administration is the obvious threat but problems run deep...

Iceberg Research announces short position in Gevo

Gevo tumbles after Iceberg Research says it's short

Gevo tumbles amid Q3 results, Iceberg Research short

Just one day after Bleecker Street Research published a short report on alternative biofuel company Gevo ($GEVO), another short-selling firm reveal...

Second Short Selling Firm in Two Days Reveals Position in Gevo (NASDAQ:GEVO)

In a report released today, Amit Dayal from H.C. Wainwright maintained a Buy rating on Gevo (GEVO – Research Report), with a price target of $14.00...

Gevo Positioned for Growth: Strategic Acquisitions and Expanding Renewable Capabilities Drive Buy Rating

The latest update is out from Gevo ( ($GEVO) ). Gevo, Inc. announced the retirement of Alisher Nurmat as Vice President Accounting and Treasurer, e...

Gevo Announces Leadership Change in Accounting Division

Contracts

Press Releases

Gevo to Acquire Red Trail Energy Assets in North Dakota, Including Operating Low-Carbon Ethanol Production and Carbon Sequestration Facilities, Expanding Platform for Sustainable Aviation Fuel, Hydrocarbons, and Chemicals

Health Care

Legal

U.S. Grants Gevo a Patent for Breakthrough Ethanol-to-Olefin Process

Gevo to Participate in Virtual Investor Meeting

Gevo, Inc. Announces Sale of Approximately $20 Million of Investment Tax Credits Generated by the Gevo NW Iowa RNG Facility Under Inflation Reduction Act, Helping to Drive Further Investment in Clean Energy

Global Carbon Dioxide Removal Market Size Expected to Reach $2.54 Billion By 2033 as Climate Change Concerns Grow

Gevo Acquires CultivateAI for its Verity Business Unit

Financing

Gevo Secures Conditional Commitment from U.S. Department of Energy Loan Programs Office for its Net-Zero 1 Sustainable Aviation Fuel Plant in South Dakota

Comments

Gevo

Notizie

Ultime notizie per Gevo (NASDAQ:GEVO) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO